ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

NOMINATION CRITERiA FOR
PROFESSIONAL ORGANIZATIONS,
REGULATORY AGENCIES, GROUP COLLABORATIVES,
AND NON-PROFIT ORGANIZATIONS

The ISMP CHEERS AWARD for Professional Organizations and Group Collaboratives is presented to groups of greater than three individuals that demonstrate exemplary commitment to furthering the science and scholarship of medication safety through innovative and creative projects, programs, educational efforts, standard setting, and/or research. The winners of this award recognize the necessity of teamwork through their actions and push the boundaries of group achievement of a common goal in medication safety.

Click here to see listing of past recipients.

Nominations are accepted from 3/31/2017 to midnight
(Eastern Time) 9/9/2017.

The ISMP CHEERS AWARD for Professional Organizations and Group Collaboratives is presented to groups that:

  • Clearly identify a high-risk, error-prone medication safety initiative that impacts large groups
  • Design and plan a safety initiative to study and improve the safety of medication use across a large population of healthcare practitioners
  • Demonstrate successful implementation of innovative, proactive medication error reduction strategies based on the ISMP philosophy and previous recommendations
  • Encourage continued momentum for the use of such medication safety strategies that stretch far beyond a few individuals or small groups
  • Demonstrate a willingness to share learning beyond the organization (e.g., presentations or articles have been written and widely disseminated; tools shared on intranet, and through newsletters)

Application for Professional Organizations and Group Collaboratives Award

Please provide brief answers to the following questions using the award criteria above. Attachments and other materials illustrating the activity or its effectiveness may be included in the submission.

The descriptive narrative should be no longer than seven double-spaced typed pages and must include:

  1. A description of the group or collaborative formed
  2. A clear description of the priority initiatives for medication safety improvements and the intended outcome
  3. A discussion of “barriers faced” or “lessons learned” from the experience
  4. A description of the strategies implemented and the process and/or outcome measurements used over time to determine present success
  5. Demonstrated examples of how this initiative is being communicated to the healthcare community at large
  6. A description of how patients were involved in the implementation strategies and/or resolution of the safety problem, or affected by the strategies and/or resolution of the problem, if applicable.

Nominations are currently closed

Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2017 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP